Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Toward defining the autoimmune microbiome for type 1 diabetes.

Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW.

ISME J. 2011 Jan;5(1):82-91. doi: 10.1038/ismej.2010.92. Epub 2010 Jul 8.

2.

Infant feeding and the risk of type 1 diabetes.

Knip M, Virtanen SM, Akerblom HK.

Am J Clin Nutr. 2010 May;91(5):1506S-1513S. doi: 10.3945/ajcn.2010.28701C. Epub 2010 Mar 24.

3.

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.

Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group.

Lancet. 2009 Jun 13;373(9680):2027-33. doi: 10.1016/S0140-6736(09)60568-7. Epub 2009 May 27.

PMID:
19481249
4.

Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German Infant Nutritional Intervention Study.

Rzehak P, Sausenthaler S, Koletzko S, Reinhardt D, von Berg A, Krämer U, Berdel D, Bollrath C, Grübl A, Bauer CP, Wichmann HE, Heinrich J; German Infant Nutritional Intervention Study Group.

Am J Clin Nutr. 2009 Jun;89(6):1846-56. doi: 10.3945/ajcn.2008.27373. Epub 2009 Apr 15.

5.

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity.

Vaarala O, Atkinson MA, Neu J.

Diabetes. 2008 Oct;57(10):2555-62. doi: 10.2337/db08-0331. Review.

6.

Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI).

von Berg A, Filipiak-Pittroff B, Krämer U, Link E, Bollrath C, Brockow I, Koletzko S, Grübl A, Heinrich J, Wichmann HE, Bauer CP, Reinhardt D, Berdel D; GINIplus study group.

J Allergy Clin Immunol. 2008 Jun;121(6):1442-7. doi: 10.1016/j.jaci.2008.04.021.

PMID:
18539195
7.

Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood.

Luopajärvi K, Savilahti E, Virtanen SM, Ilonen J, Knip M, Akerblom HK, Vaarala O.

Pediatr Diabetes. 2008 Oct;9(5):434-41. doi: 10.1111/j.1399-5448.2008.00413.x. Epub 2008 May 21.

8.

Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study.

Harjutsalo V, Sjöberg L, Tuomilehto J.

Lancet. 2008 May 24;371(9626):1777-82. doi: 10.1016/S0140-6736(08)60765-5.

PMID:
18502302
9.

Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).

TRIGR Study Group.

Pediatr Diabetes. 2007 Jun;8(3):117-37.

PMID:
17550422
10.

Factors influencing the composition of the intestinal microbiota in early infancy.

Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE.

Pediatrics. 2006 Aug;118(2):511-21.

PMID:
16882802
11.

Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes.

Virtanen SM, Kenward MG, Erkkola M, Kautiainen S, Kronberg-Kippilä C, Hakulinen T, Ahonen S, Uusitalo L, Niinistö S, Veijola R, Simell O, Ilonen J, Knip M.

Diabetologia. 2006 Jul;49(7):1512-21. Epub 2006 Apr 5.

PMID:
16596359
12.

Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.

Akerblom HK, Virtanen SM, Ilonen J, Savilahti E, Vaarala O, Reunanen A, Teramo K, Hämäläinen AM, Paronen J, Riikjärv MA, Ormisson A, Ludvigsson J, Dosch HM, Hakulinen T, Knip M; National TRIGR Study Groups.

Diabetologia. 2005 May;48(5):829-37. Epub 2005 Apr 19. Erratum in: Diabetologia. 2005 Aug;48(8):1676. Riikjärv, MA [added]; Ormisson, A [added]; Ludvigsson, J [added]; Dosch, HM [added]; Hakulinen, T [added]; Knip, M [added].

PMID:
15838685
13.

In vitro-deranged intestinal immune response to gliadin in type 1 diabetes.

Auricchio R, Paparo F, Maglio M, Franzese A, Lombardi F, Valerio G, Nardone G, Percopo S, Greco L, Troncone R.

Diabetes. 2004 Jul;53(7):1680-3.

14.

Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age.

Virtanen SM, Knip M.

Am J Clin Nutr. 2003 Dec;78(6):1053-67. Review.

15.

Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes.

Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E.

Diabetes. 2003 Sep;52(9):2287-95.

16.

The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial.

von Berg A, Koletzko S, Grübl A, Filipiak-Pittroff B, Wichmann HE, Bauer CP, Reinhardt D, Berdel D; German Infant Nutritional Intervention Study Group.

J Allergy Clin Immunol. 2003 Mar;111(3):533-40.

PMID:
12642834
17.

Protein-free diets do not protect high-incidence diabetes-prone BioBreeding rats from diabetes.

Simonson W, Ramanathan S, Bieg S, Poussier P, Lernmark A.

Metabolism. 2002 May;51(5):569-74.

PMID:
11979387
18.

Natural course of preclinical type 1 diabetes.

Knip M.

Horm Res. 2002;57 Suppl 1:6-11. Review.

PMID:
11979015
19.

The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.

Kimpimäki T, Kupila A, Hämäläinen AM, Kukko M, Kulmala P, Savola K, Simell T, Keskinen P, Ilonen J, Simell O, Knip M.

J Clin Endocrinol Metab. 2001 Oct;86(10):4782-8.

PMID:
11600541
20.

Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.

Kimpimäki T, Kulmala P, Savola K, Vähäsalo P, Reijonen H, Ilonen J, Akerblom HK, Knip M.

J Clin Endocrinol Metab. 2000 Mar;85(3):1126-32.

PMID:
10720050

Supplemental Content

Support Center